Publications by authors named "Colin Marchant"

Claim this Profile
A
A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
Melissa S Stockwell, Colin D Marchant, A Patrica Wodi, Elizabeth D Barnett, Karen R Broder

Vaccine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children.
Anita M Loughlin, Katherine Hsu, Amy L Silverio, Colin D Marchant, Stephen I Pelton

Pediatr Infect Dis J· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age.
Gary S Marshall, Mark Blatter, Colin Marchant, Emmanuel Aris, Narcisa Mesaros

Pediatr Infect Dis J· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive assessment of serious adverse events following immunization by health care providers.
S Elizabeth Williams, Kathryn M Edwards, Roger P Baxter, Philip S LaRussa, Neal A Halsey, Colin D Marchant

J Pediatr· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.
Barbara A Pahud, S Elizabeth Williams, Cornelia L Dekker, Neal Halsey, Philip Larussa, Colin D Marchant

Pediatr Infect Dis J· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologically plausible and evidence-based risk intervals in immunization safety research.
Ali Rowhani-Rahbar, Nicola P Klein, Cornelia L Dekker, Kathryn M Edwards, Colin D Marchant

Vaccine· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Anita M Loughlin, Colin D Marchant, William Adams, Elizabeth Barnett, Roger Baxter

Vaccine· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Algorithm to assess causality after individual adverse events following immunizations.
Neal A Halsey, Kathryn M Edwards, Cornelia L Dekker, Nicola P Klein, Roger Baxter, Colin Marchant

Vaccine· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials.
Kristina Bryant, Jodie McVernon, Colin Marchant, Terry Nolan, Gary Marshall

Hum Vaccin Immunother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011.
James D Cherry, Tina Tan, Carl-Heinz Wirsing von König, Kevin D Forsyth, Usa Thisyakorn, Colin Marchant

Clin Infect Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and genetic diversity of nontypeable haemophilus influenzae in the respiratory tract of infants and primary caregivers.
Sandra K Schumacher, Colin D Marchant, Anita M Loughlin, Valérie Bouchet, Abbie Stevenson

Pediatr Infect Dis J· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing the next generation of vaccinologists.
Nicola P Klein, Jane Gidudu, Yandong Qiang, Barbara Pahud, Ali Rowhani-Rahbar, Colin Marchant

Vaccine· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination.
S Elizabeth Williams, Barbara A Pahud, Claudia Vellozzi, Peter D Donofrio, Cornelia L Dekker, Colin D Marchant

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.
S Elizabeth Williams, Nicola P Klein, Neal Halsey, Cornelia L Dekker, Roger P Baxter, Colin D Marchant

Vaccine· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.
Kristina A Bryant, Gary S Marshall, Colin D Marchant, Noris Pavia-Ruiz, Terry Nolan

Pediatrics· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
Philip S LaRussa, Kathryn M Edwards, Cornelia L Dekker, Nicola P Klein, Neal A Halsey, Colin Marchant

Pediatrics· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age.
E Kathryn Miller, Logan Dumitrescu, Chelsea Cupp, Stacy Dorris, Sallee Taylor, Colin Marchant

Vaccine· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
Gary S Marshall, Colin D Marchant, Mark Blatter, Leonard R Friedland, Emmanuel Aris

Hum Vaccin· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and immunogenicity of gardasil given concomitantly with Menactra and Adacel.
Keith S Reisinger, Stan L Block, Michelle Collins-Ogle, Colin Marchant, Melissa Catlett

Pediatrics· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY) at 12 to 15 months of age.
Gary S Marshall, Colin D Marchant, Mark Blatter, Emmanuel Aris, Dominique Boutriau

Pediatr Infect Dis J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Colin D Marchant, Jacqueline M Miller, Gary S Marshall, Mark Blatter, Emmanuel Aris

Pediatr Infect Dis J· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.
Andrew F Trofa, Michael Levin, Colin D Marchant, James Hedrick, Mark M Blatter

Pediatr Infect Dis J· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal hepatitis A vaccination in the United States: a call for action.
Jay M Lieberman, Bonnie M Word, R Jake Jacobs, Ron Dagan, Colin D Marchant

Pediatr Infect Dis J· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Terry Nolan, David I Bernstein, Stan L Block, Milo Hilty, Harry L Keyserling, Colin Marchant

Pediatrics· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
Anna R Giuliano, Eduardo Lazcano-Ponce, Luisa Villa, Terry Nolan, Colin Marchant

J Infect Dis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis